Companies to explore

0 results

    No published company or research matches your search. Try a name or ticker.

    Verdict: Invest

    Română
    NYSE · United States

    Morgan Stanley (MS)

    Investment Services

    InvestableWait
    $180.57
    Close
    Oct 16, 2026
    -0.84% last session
    Reported revenue
    $34.47 bn
    Q2 2026
    Annual revenue growth
    17.4%
    Q2 2026
    Operating margin
    21.3%
    Q2 2026
    Reported P/E
    14.58×
    2026-10-14
    PRICE PERFORMANCE

    1.Share price

    $181.51+$26.17 (+16.85%)from period start
    One year of daily closes$237$207$176$145Oct 25Jan 26Apr 26Jul 26Oct 26

    Daily closes, adjusted for stock splits. Price return excludes dividends. Hover or tap to explore.

    2.Company news

    View all
    OUR VERDICT

    3.Our verdict

    Waiting for a better price

    The published targets do not meet our required upside.

    Assessed at $180.57 · 12-month horizon

    Analyst price targets · 12 months

    Published analyst targets, compared with our dated share price.

    Average target
    $213.27
    Price potential
    +18.1%
    Analysts
    25
    Low–high range
    $185.00$262.00
    Historical SPY reference · 5 years
    +11.1%
    Average target versus SPY hurdle
    7 pp
    Buy threshold below
    $179.79

    Why now

    • The company delivers the operating progress reflected in analyst expectations.

    What would change our view

    • Analyst targets or the reported financial position deteriorate.
    RESEARCH AT PUBLICATION

    4.Investment case at publication

    Morgan Stanley’s wealth franchise anchors a powerful markets business

    The June fiscal quarter brought stronger reported profitability, but banking cash movements require a different reading from the earnings statement.

    Morgan Stanley’s business strength lies in combining client wealth management with institutional financial services. The reported June fiscal quarter supports that assessment through higher revenue, operating margin and diluted earnings against the same fiscal quarter of the prior year, without establishing which franchise drove the gains.

    1. Wealth and asset management provide a substantial income base alongside investment banking and institutional trading.

    2. Reported revenue, operating margin and diluted earnings improved against the same fiscal quarter of the prior year.

    3. Negative operating cash flow needs a banking-specific interpretation; the available figures do not establish financial distress or distributable cash.

    5.Latest quarter

    Morgan Stanley’s June fiscal quarter showed a more profitable consolidated business than the same fiscal quarter of the prior year. Reported revenue rose, operating margin widened and diluted earnings per share increased.

    These results establish stronger reported performance, but not its source. The available statements do not separate the contribution from wealth management, investment banking or institutional trading.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Reported revenueQ2 2026$34.47 bn
    Annual revenue growthQ2 202617.4%
    Reported operating incomeQ2 2026$7.35 bn
    Operating marginQ2 202621.3%
    Profit per share, after dilutionQ2 2026$3.46

    6.The business

    Morgan Stanley manages client wealth and provides investment banking and trading services.

    We like the breadth of this franchise. Morgan Stanley pairs the everyday work of managing client money with a formidable presence in institutional finance. Its strongest opportunity is to make that combination more valuable to clients, drawing on a substantial wealth platform rather than relying solely on deal activity.

    It is also a bank holding company. Customer deposits predominantly originate from cash swept out of wealth management and brokerage accounts, tying its banking funding base closely to its client businesses.

    7.Growth

    Reported consolidated revenue in the June fiscal quarter exceeded the same fiscal quarter of the prior year. It also exceeded the preceding fiscal quarter, showing that the revenue expansion was not limited to the annual comparison.

    The company earns income through managing assets, serving brokerage clients, advising on transactions and facilitating institutional trading. These activities respond to different client needs, but the available figures do not identify their individual growth contributions. Reported total revenue should not be treated as net interest income or an issuer-defined net revenue measure.

    Revenue history

    $ bn
    Revenue
    Revenue historyConsolidated reported quarterly revenue; compare the same fiscal quarter across years. Unit: $ bn.$37$27$18$9$0Q3 2023 · Revenue: $23.42 bnQ4 2023 · Revenue: $23.83 bnQ1 2024 · Revenue: $26.27 bnQ2 2024 · Revenue: $26.48 bnQ3 2024 · Revenue: $27.37 bnQ4 2024 · Revenue: $27.16 bnQ1 2025 · Revenue: $29.13 bnQ2 2025 · Revenue: $29.35 bnQ3 2025 · Revenue: $31.19 bnQ4 2025 · Revenue: $29.99 bnQ1 2026 · Revenue: $33.15 bnQ2 2026 · Revenue: $34.47 bnQ3 2023Q1 2024Q3 2024Q2 2025Q4 2025Q2 2026Revenue historyConsolidated reported quarterly revenue; compare the same fiscal quarter across years. Unit: $ bn.$37$27$18$9$0Q3 2023 · Revenue: $23.42 bnQ4 2023 · Revenue: $23.83 bnQ1 2024 · Revenue: $26.27 bnQ2 2024 · Revenue: $26.48 bnQ3 2024 · Revenue: $27.37 bnQ4 2024 · Revenue: $27.16 bnQ1 2025 · Revenue: $29.13 bnQ2 2025 · Revenue: $29.35 bnQ3 2025 · Revenue: $31.19 bnQ4 2025 · Revenue: $29.99 bnQ1 2026 · Revenue: $33.15 bnQ2 2026 · Revenue: $34.47 bnQ3 2023Q1 2025Q2 2026

    Consolidated reported quarterly revenue; compare the same fiscal quarter across years.

    View chart data
    Revenue history
    PeriodRevenue ($ bn)
    Q3 2023$23.42
    Q4 2023$23.83
    Q1 2024$26.27
    Q2 2024$26.48
    Q3 2024$27.37
    Q4 2024$27.16
    Q1 2025$29.13
    Q2 2025$29.35
    Q3 2025$31.19
    Q4 2025$29.99
    Q1 2026$33.15
    Q2 2026$34.47

    8.Profitability

    Operating margin measures the share of reported revenue left as reported operating income. In the June fiscal quarter, that share was higher than in the same fiscal quarter of the prior year and slightly higher than in the preceding fiscal quarter.

    The result shows that operating income grew faster than revenue against the same fiscal quarter of the prior year. It does not establish whether the improvement came from spending discipline, business mix or other factors, because the necessary expense and segment detail is unavailable.

    Operating margin

    %
    Operating margin
    Operating marginReported consolidated operating income divided by revenue. Missing provider fields remain unavailable. Unit: %.22.318.715.111.47.8Q3 2023 · Operating margin: 13.43 %Q4 2023 · Operating margin: 8.8 %Q1 2024 · Operating margin: 16.73 %Q2 2024 · Operating margin: 15.38 %Q3 2024 · Operating margin: 15.42 %Q4 2024 · Operating margin: 18.06 %Q1 2025 · Operating margin: 19.03 %Q2 2025 · Operating margin: 15.75 %Q3 2025 · Operating margin: 19.33 %Q4 2025 · Operating margin: 19.21 %Q1 2026 · Operating margin: 21.15 %Q2 2026 · Operating margin: 21.32 %Q3 2023Q1 2024Q3 2024Q2 2025Q4 2025Q2 2026Operating marginReported consolidated operating income divided by revenue. Missing provider fields remain unavailable. Unit: %.22.318.715.111.47.8Q3 2023 · Operating margin: 13.43 %Q4 2023 · Operating margin: 8.8 %Q1 2024 · Operating margin: 16.73 %Q2 2024 · Operating margin: 15.38 %Q3 2024 · Operating margin: 15.42 %Q4 2024 · Operating margin: 18.06 %Q1 2025 · Operating margin: 19.03 %Q2 2025 · Operating margin: 15.75 %Q3 2025 · Operating margin: 19.33 %Q4 2025 · Operating margin: 19.21 %Q1 2026 · Operating margin: 21.15 %Q2 2026 · Operating margin: 21.32 %Q3 2023Q1 2025Q2 2026

    Reported consolidated operating income divided by revenue. Missing provider fields remain unavailable.

    View chart data
    Operating margin
    PeriodOperating margin (%)
    Q3 202313.43
    Q4 20238.8
    Q1 202416.73
    Q2 202415.38
    Q3 202415.42
    Q4 202418.06
    Q1 202519.03
    Q2 202515.75
    Q3 202519.33
    Q4 202519.21
    Q1 202621.15
    Q2 202621.32

    9.Earnings

    Reported diluted earnings per share increased against both the same fiscal quarter of the prior year and the preceding fiscal quarter. This measure spreads earnings attributable to shareholders across the diluted weighted-average share base.

    The available consolidated net income and share figures should retain their reported definitions. They do not establish a buyback contribution to earnings growth, and no adjusted earnings reconciliation is available.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Other non-operating incomeQ2 2026$0 bn
    Reported consolidated net incomeQ2 2026$5.65 bn
    Average shares, including potential dilutionQ2 20261.57 bn shares

    Reported diluted EPS

    $
    Diluted EPS
    Reported diluted EPSThe published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred. Unit: $.$3.67$2.75$1.83$0.92$0Q3 2023 · Diluted EPS: $1.38Q4 2023 · Diluted EPS: $0.85Q1 2024 · Diluted EPS: $2.02Q2 2024 · Diluted EPS: $1.82Q3 2024 · Diluted EPS: $1.88Q4 2024 · Diluted EPS: $2.22Q1 2025 · Diluted EPS: $2.6Q2 2025 · Diluted EPS: $2.13Q3 2025 · Diluted EPS: $2.8Q4 2025 · Diluted EPS: $2.68Q1 2026 · Diluted EPS: $3.43Q2 2026 · Diluted EPS: $3.46Q3 2023Q1 2024Q3 2024Q2 2025Q4 2025Q2 2026Reported diluted EPSThe published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred. Unit: $.$3.67$2.75$1.83$0.92$0Q3 2023 · Diluted EPS: $1.38Q4 2023 · Diluted EPS: $0.85Q1 2024 · Diluted EPS: $2.02Q2 2024 · Diluted EPS: $1.82Q3 2024 · Diluted EPS: $1.88Q4 2024 · Diluted EPS: $2.22Q1 2025 · Diluted EPS: $2.6Q2 2025 · Diluted EPS: $2.13Q3 2025 · Diluted EPS: $2.8Q4 2025 · Diluted EPS: $2.68Q1 2026 · Diluted EPS: $3.43Q2 2026 · Diluted EPS: $3.46Q3 2023Q1 2025Q2 2026

    The published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred.

    View chart data
    Reported diluted EPS
    PeriodDiluted EPS ($)
    Q3 2023$1.38
    Q4 2023$0.85
    Q1 2024$2.02
    Q2 2024$1.82
    Q3 2024$1.88
    Q4 2024$2.22
    Q1 2025$2.6
    Q2 2025$2.13
    Q3 2025$2.8
    Q4 2025$2.68
    Q1 2026$3.43
    Q2 2026$3.46

    10.Cash flow

    For the reported June fiscal quarter, operating cash flow was negative, whereas it was positive in the same fiscal quarter of the prior year. Gross cash purchases of property, plant and equipment were higher than in that prior-year quarter. The available detail does not identify what those purchases funded.

    For the trailing twelve months ended at the June quarter-end, operating cash flow was also negative. Operating cash flow less gross cash purchases of property, plant and equipment was negative for both that trailing period and the reported quarter.

    Bank cash-flow statements include movements associated with deposits and lending, so a negative figure alone does not establish distress. The derived cash-after-purchases measure excludes asset sales, intangible investment, leases and noncash commitments; it is neither issuer-defined free cash flow nor distributable bank earnings.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Cash generated by operationsTTM 2026-06-30-$15.59 bn
    Cash after investmentsTTM 2026-06-30-$18.58 bn
    Cash generated by operationsQ2 2026-$2.75 bn
    Building and equipment investmentsQ2 2026$0.82 bn
    Cash after investmentsQ2 2026-$3.57 bn

    Cash generated versus cash invested

    $ bn
    Operating cash flowGross cash PPE purchasesOCF less gross PPE purchases
    Cash generated versus cash investedMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable. Unit: $ bn.$15$4-$6-$17-$28Q3 2024 · Operating cash flow: -$17.32 bnQ4 2024 · Operating cash flow: $11.8 bnQ1 2025 · Operating cash flow: -$23.98 bnQ2 2025 · Operating cash flow: $11.83 bnQ3 2025 · Operating cash flow: -$3.33 bnQ4 2025 · Operating cash flow: -$2.41 bnQ1 2026 · Operating cash flow: -$7.1 bnQ2 2026 · Operating cash flow: -$2.75 bnQ3 2024 · Gross cash PPE purchases: $0.92 bnQ4 2024 · Gross cash PPE purchases: $0.88 bnQ1 2025 · Gross cash PPE purchases: $0.71 bnQ2 2025 · Gross cash PPE purchases: $0.76 bnQ3 2025 · Gross cash PPE purchases: $0.71 bnQ4 2025 · Gross cash PPE purchases: $0.71 bnQ1 2026 · Gross cash PPE purchases: $0.75 bnQ2 2026 · Gross cash PPE purchases: $0.82 bnQ3 2024 · OCF less gross PPE purchases: -$18.24 bnQ4 2024 · OCF less gross PPE purchases: $10.92 bnQ1 2025 · OCF less gross PPE purchases: -$24.69 bnQ2 2025 · OCF less gross PPE purchases: $11.07 bnQ3 2025 · OCF less gross PPE purchases: -$4.05 bnQ4 2025 · OCF less gross PPE purchases: -$3.12 bnQ1 2026 · OCF less gross PPE purchases: -$7.85 bnQ2 2026 · OCF less gross PPE purchases: -$3.57 bnQ3 2024Q4 2024Q2 2025Q3 2025Q1 2026Q2 2026Cash generated versus cash investedMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable. Unit: $ bn.$15$4-$6-$17-$28Q3 2024 · Operating cash flow: -$17.32 bnQ4 2024 · Operating cash flow: $11.8 bnQ1 2025 · Operating cash flow: -$23.98 bnQ2 2025 · Operating cash flow: $11.83 bnQ3 2025 · Operating cash flow: -$3.33 bnQ4 2025 · Operating cash flow: -$2.41 bnQ1 2026 · Operating cash flow: -$7.1 bnQ2 2026 · Operating cash flow: -$2.75 bnQ3 2024 · Gross cash PPE purchases: $0.92 bnQ4 2024 · Gross cash PPE purchases: $0.88 bnQ1 2025 · Gross cash PPE purchases: $0.71 bnQ2 2025 · Gross cash PPE purchases: $0.76 bnQ3 2025 · Gross cash PPE purchases: $0.71 bnQ4 2025 · Gross cash PPE purchases: $0.71 bnQ1 2026 · Gross cash PPE purchases: $0.75 bnQ2 2026 · Gross cash PPE purchases: $0.82 bnQ3 2024 · OCF less gross PPE purchases: -$18.24 bnQ4 2024 · OCF less gross PPE purchases: $10.92 bnQ1 2025 · OCF less gross PPE purchases: -$24.69 bnQ2 2025 · OCF less gross PPE purchases: $11.07 bnQ3 2025 · OCF less gross PPE purchases: -$4.05 bnQ4 2025 · OCF less gross PPE purchases: -$3.12 bnQ1 2026 · OCF less gross PPE purchases: -$7.85 bnQ2 2026 · OCF less gross PPE purchases: -$3.57 bnQ3 2024Q3 2025Q2 2026

    Massive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable.

    View chart data
    Cash generated versus cash invested
    PeriodOperating cash flow ($ bn)Gross cash PPE purchases ($ bn)OCF less gross PPE purchases ($ bn)
    Q3 2024-$17.32$0.92-$18.24
    Q4 2024$11.8$0.88$10.92
    Q1 2025-$23.98$0.71-$24.69
    Q2 2025$11.83$0.76$11.07
    Q3 2025-$3.33$0.71-$4.05
    Q4 2025-$2.41$0.71-$3.12
    Q1 2026-$7.1$0.75-$7.85
    Q2 2026-$2.75$0.82-$3.57

    11.Balance sheet

    Morgan Stanley reports substantial cash, short-term investments and noncurrent debt and capital lease obligations at the June quarter-end. Customer deposits also form part of its banking funding model, rather than representing ordinary industrial-company borrowing.

    Short-term investments should not automatically be treated as cash available to repay debt. The reported categories do not show asset encumbrance, regulatory capital strength or the full funding maturity profile. Market exposure and the need to maintain dependable funding are material risks for this business.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Cash and readily available funds2026-06-30$160.14 bn
    Short-term investments2026-06-30$1,008.31 bn
    Short-term debt2026-06-30$0 bn
    Long-term debt and leases2026-06-30$443.11 bn

    12.Valuation

    The current analyst targets and SPY comparison are shown in Our verdict.

    View the current assessment

    13.What we are watching

    The next useful evidence is a clearer account of which businesses generated the revenue and margin gains. Wealth client assets, client cash balances and institutional activity would help distinguish the durability of the income base from market-sensitive performance.

    Funding disclosures and regulatory capital measures also deserve attention. They would add meaning to the reported balance sheet and help explain negative operating cash movements without confusing them with an earnings shortfall.